UCFA
CTIC

United Capital Financial Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

United Capital Financial Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,555
Closed -$100K – 1385
2018
Q1 		$100K Sell
25,555
-27,621
-52% -$97.1K ﹤0.01% 1275
2017
Q4 		$143K Buy
53,176
+555
+1% +$1.63K ﹤0.01% 1262
2017
Q3 		$168K Hold
52,621
– – ﹤0.01% 1247
2017
Q2 		$157K Hold
52,621
– – ﹤0.01% 1233
2017
Q1 		$221K Hold
52,621
– – ﹤0.01% 1158
2016
Q4 		$2.16M Hold
52,621
– – 0.02% 547
2016
Q3 		$195K Hold
52,621
– – ﹤0.01% 1192
2016
Q2 		$0 Hold
52,621
– – ﹤0.01% 1322
2016
Q1 		$279K Buy
52,621
+6,521
+14% +$52.1K ﹤0.01% 1021
2015
Q4 		$567K Sell
46,100
-3,000
-6% -$40K 0.01% 855
2015
Q3 		$717K Buy
49,100
+15,076
+44% +$261K 0.01% 792
2015
Q2 		$663K Buy
34,024
+18,967
+126% +$366K 0.01% 824
2015
Q1 		$268K Hold
15,057
– – ﹤0.01% 1103
2014
Q4 		$355K Hold
15,057
– – 0.01% 920
2014
Q3 		$364K Sell
15,057
-1,797
-11% -$46.7K 0.01% 883
2014
Q2 		$474K Sell
16,854
-2,400
-12% -$72.1K 0.01% 692
2014
Q1 		$655K Buy
19,254
+6,030
+46% +$206K 0.01% 581
2013
Q4 		$253K Hold
13,224
– – 0.01% 565
2013
Q3 		$214K Buy
+13,224
New +$153K 0.01% 625

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

United Capital Financial Advisors's CTIC Position: Q2 2018 in Review

United Capital Financial Advisors sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2018, closing a stake of 25,555 shares — an estimated $100K sold.

United Capital Financial Advisors first reported a position in CTIC in Q3 2013 and held it in 19 quarters. The position peaked at $2.16M in Q4 2016. 83 funds tracked by Wall St. Rank hold CTIC as of Q2 2018.

  • United Capital Financial Advisors reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2018 after selling out during the quarter.
  • United Capital Financial Advisors sold 25,555 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2018, an estimated $100K.
  • United Capital Financial Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2013 and held it in 19 quarters.
  • United Capital Financial Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $2.16M in Q4 2016.
  • 83 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2018.

Based on United Capital Financial Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.